DalsnaFinance › IPOs › Neumora Therapeutics › IPO
Neumora Therapeutics, Inc. completed its initial public offering on NASDAQ on September 15, 2023, pricing at $17.00 a share.
| Ticker | NMRA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 15, 2023 |
| Offering price | $17.00 |
| Shares offered | 14,710,000 |
| Total raised | $250M |
Neumora Therapeutics, Inc. sold 14,710,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $250.1 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $250 million total recorded for the deal.
Neumora Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Neumora Therapeutics, Inc.. This page is general information, not investment advice.